{"id":447048,"title":"Notice to Stakeholders: Release of the Product Monograph Template - Schedule D - Biosimilar Biologic Drug - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:28:05.903000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-release-product-monograph-template-schedule-d-biosimilar-biologic-drug.html?wbdisable=false","snippet":"Notice to Stakeholders: Release of the Product Monograph Template - Schedule D - Biosimilar Biologic Drug May 15, 2017 Our file number: 17-105256-845 Health Canada is pleased to announce the release of the Product Monograph Template - Schedule D - Biosimilar Biologic Drug . This…","rawSnapshotUrl":"/api/snapshots/raw/447048","browseUrl":"https://replay.healtharchive.ca/job-6/20260103132805/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-release-product-monograph-template-schedule-d-biosimilar-biologic-drug.html?wbdisable=false#ha_snapshot=447048","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}